World Health Organization reference values for human semen characteristics*‡
Trevor G. Cooper(Institute of Reproductive Medicine), Kirsten M. Vogelsong(World Health Organization), Jacques Auger(Délégation Paris 5), Hermann M. Behre(University Hospital in Halle), Christina Wang(University of California, Los Angeles), Thinus F. Kruger, H.W.G. Baker(Royal Women's Hospital), Elizabeth Noonan(Fred Hutch Cancer Center), Michael T. Mbizvo(National HIV/AIDS/STI/TB Council), Sigrid von Eckardstein(World Health Organization), Trine B. Haugen(Norwegian Institute of Marine Research)
Cited by 2,849
Related Papers
Decline in Semen Quality among Fertile Men in Paris during the Past 20 Years
|New England Journal of Medicine|1995|1.1k
Effects of Testosterone Treatment in Older Men
|New England Journal of Medicine|2016|864
Investigation, treatment and monitoring of late-onset hypogonadism in males
|European Journal of Endocrinology|2008|855
Long-Term Testosterone Gel (AndroGel) Treatment Maintains Beneficial Effects on Sexual Function and Mood, Lean and Fat Mass, and Bone Mineral Density in Hypogonadal Men
|The Journal of Clinical Endocrinology & Metabolism|2004|652
Regional differences in semen quality in Europe
|Human Reproduction|2001|453